BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
98.09
+0.01 (0.01%)
At close: Sep 26, 2025, 4:00 PM EDT
98.08
-0.01 (-0.01%)
After-hours: Sep 26, 2025, 4:10 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $23.58 billion as of September 26, 2025. Its market cap has decreased by -1.44% in one year.
Market Cap
23.58B
Enterprise Value
7.21B
1-Year Change
-1.44%
Ranking
Category
Stock Price
$98.09
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $23.58B, an increase of 687.34%. That is a compound annual growth rate of 41.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 23.58B | -13.69% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |